Multi-center experience using Sofosbuvir & ribavirin with and without pegylated interferon to treat hepatitis C patients with and without liver cirrhosis (RESiP study: Real-life experience with sofosbuvir in Pakistan)

Authors
Category Primary study
JournalHepatology
Year 2016
This article has no abstract
Epistemonikos ID: 5145e5774388abb4222d66ee44f8f2755b54f3aa
First added on: Feb 08, 2025